Evidence map›Paper›PMID 19397475›Full record

ReviewExpert opinion on therapeutic targets2009

ADAM8: a new therapeutic target for asthma.

Martin D Knolle, Caroline A Owen

Open access · greenAbstract readReview
In one paragraph

Review in Expert opinion on therapeutic targets, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 65 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Obesity impairs apoptotic cell clearance in asthma.The Journal of allergy and clinical immunology · 2013
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Martin D KnolleBrigham and Women's Hospital, Harvard Medical School, Division of Pulmonary and Critical Care Medicine, 905 Thorn Building, 75 Francis Street, Boston, MA 02115, USA.
Caroline A Owen
Brigham and Women's Hospital · US

Funding

RESPIRATORY RESEARCHT32HL007633 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI George R Washko · 1985 to 2026
$14.9M
Novel Roles for MMP-8 in Acute Lung InjuryR01HL063137 · NHLBI · UNIVERSITY OF UTAH · PI OWEN, CAROLINE A · 1999 to 2008
$2.6M
Novel Roles for ADAM15 in Acute Lung InjuryR01HL086814 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI OWEN, CAROLINE A · 2007 to 2010
$1.6M
Investigating the Role of ADAM8 in Allergic Airway InflammationF32HL095276 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI KNOLLE, MARTIN DANIEL · 2009 to 2009
$55k
NHLBI NIH HHS F32 HL095276NHLBI NIH HHS R01 HL063137NHLBI NIH HHS R01 HL086814NHLBI NIH HHS T32 HL007633
6 · The paper itself

Abstract

backgroundA proteinase with a disintegrin and a metalloproteinase domain-8 (ADAM8) has been linked to asthma.

objectiveTo explore whether ADAM8 is a therapeutic target for asthma.

methodsWe reviewed literature on ADAM8's function and expression and activities in lungs of humans and mice with allergic airway inflammation (AAI). We used these data to generate hypotheses about the contributions of ADAM8 to asthma pathogenesis.

conclusionsADAM8 levels are increased in airway epithelium and airway inflammatory cells in mice with AAI and human asthma patients. Data from murine models of AAI indicate that ADAM8 dampens airway inflammation. It is not clear whether ADAM8 contributes directly to structural remodeling in asthmatic airways. Additional studies are required to validate ADAM8 as a therapeutic target for asthma.

Indexed as

Drug Delivery SystemsADAM ProteinsAnimalsAnti-Asthmatic AgentsAntigens, CDAsthmaChildCytokinesDrug Evaluation, PreclinicalEpithelial CellsExtracellular Matrix ProteinsFibrosisHumansLeukocytesLungMembrane ProteinsADAM8 protein, humanAdam8 protein, mouseADAM ProteinsAnti-Asthmatic AgentsAntigens, CDCytokinesExtracellular Matrix ProteinsMembrane ProteinsProtease InhibitorsReceptors, Cell Surface

Identifiers

PMID19397475
PMCPMC2784995
OpenAlexW2031228650

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.